| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.1M | — | — |
| Cost of Revenue | $628K | — | — |
| Gross Profit | $1.5M | — | — |
| R&D Expense | $37K | — | +22.0% |
| SG&A Expense | $997K | — | +192.8% |
| Operating Income | $426K | — | +214.9% |
| Interest Expense | $3K | — | +0.0% |
| Pre-tax Income | $488K | — | +230.6% |
| Income Tax | $137K | — | — |
| Net Income | $352K | — | +194.0% |
| EPS (Basic) | $0.03 | — | +130.0% |
| EPS (Diluted) | $0.02 | — | +120.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.6M | +48.5% | — |
| Accounts Receivable | $1.4M | -32.6% | — |
| Current Assets | $6.2M | -5.6% | +5930.6% |
| Total Assets | $11.8M | +9.9% | +3208.2% |
| Current Liabilities | $2.9M | -29.6% | +247.6% |
| Total Liabilities | $2.9M | -29.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $67K | — | +117.9% |
| Capital Expenditures | $518K | — | — |
| Investing Cash Flow | -$518K | — | — |
| Financing Cash Flow | $2.0M | — | +464.3% |
| Free Cash Flow | -$451K | — | — |
| +241.5% |
| Stockholders' Equity | $8.9M | +35.0% | +1865.6% |